Literature DB >> 830926

Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis.

S Nouisa-Arvanitakis, F B Stapleton, M A Linshaw, J Kennedy.   

Abstract

The relationship between the dosage of pancreatic extract and the excretion of uric acid was investigated in 29 patients with cystic fibrosis and exocrine pancreatic insufficiency. Urinary excretion of uric acid was normal in patients receiving small doses of pancreatic extracts and abnormally high in those receiving large amounts. In the latter group, normouricosuria was achieved by reducing the dose of pancreatic extract. Normal stool patterns and adequate weight gains were preserved by a diet modification that was well accepted by the patients. To eliminate the potential renal consequences of hyperuricosuria, it seems appropriate to control the need for increasing amounts of pancreatic enzymes by limiting the dietary intake of fat and maintaining a positive caloric and nitrogen balance with high intake of protein and carbohydrates and supplementation with medium-chain triglycerides.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830926     DOI: 10.1016/s0022-3476(77)80657-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

Review 1.  Pathogenesis and management of arthropathy in cystic fibrosis.

Authors:  B M Phillips; T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

2.  Gout and hyperuricaemia in adults with cystic fibrosis.

Authors:  Alex Horsley; Jennifer Helm; Amanda Brennan; Rowland Bright-Thomas; Kevin Webb; Andrew Jones
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

3.  Studies on the quality of pancreatic preparations: enzyme content, prospective bioavailability, bile acid pattern, and contamination with purines.

Authors:  K H Niessen; J König; M Molitor; B Neef
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

4.  Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.

Authors:  P L Zentler-Munro; D R Fine; J C Batten; T C Northfield
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

5.  Cystic fibrosis and calcium oxalate nephrolithiasis.

Authors:  A S Chidekel; T F Dolan
Journal:  Yale J Biol Med       Date:  1996 Jul-Aug

Review 6.  Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management.

Authors:  Adithya M Pathanki; Joseph A Attard; Elizabeth Bradley; Sarah Powell-Brett; Bobby V M Dasari; John R Isaac; Keith J Roberts; Nikolaos A Chatzizacharias
Journal:  World J Gastrointest Pathophysiol       Date:  2020-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.